ABSTRACT
The current era of medicine designs treatments and therapies for
the general population, despite the risk of unintentional adverse
effects in certain subgroups of patients. While ethnicity has been
stressed in clinical trials, there could be varied outcomes within
a particular ethnic group due to unique genetic profiles and
underlying disorders. The modality of generalized treatments may
be supplemented or even replaced by personalized medicine due
to the rapid expansion in the fields of genomics and molecular di-
agnostics. Personalized medicine is based on tailoring therapeutics
to the individual characteristics of each patient [1]. By classifying
individuals into subpopulations, depending on susceptibility to a
particular disease or response to a specific treatment, the efficacy of
medical treatments can bemaximized, while minimizing unforeseen
negative effects.
